Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.910
-0.090 (-2.25%)
Oct 10, 2025, 1:36 PM EDT - Market open
Silexion Therapeutics Employees
As of December 31, 2024, Silexion Therapeutics had 14 total employees, including 11 full-time and 3 part-time employees.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,174,500
Market Cap
2.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SLXN News
- 10 days ago - Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer - GlobeNewsWire
- 15 days ago - Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 4 weeks ago - Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data - Benzinga
- 4 weeks ago - Silexion Therapeutics Announces Pricing of $6.0 Million Public Offering - GlobeNewsWire
- 4 weeks ago - Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration - GlobeNewsWire
- 5 weeks ago - Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204 - GlobeNewsWire
- 5 weeks ago - Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 2 months ago - Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire